Earlier in March, the Chinese NMPA issued new regulations for API DMFs in China. Now, DMF manufacturers need to pay the NMPA about $50,000 to get their APIs activated in China whereas there used to be no government fee. Also, more documents are needed. The following documents and samples are required... Read More
Medical institutions in Shanghai that provide online diagnosis and treatment during the COVID-19 outbreak will now be eligible for reimbursement by China’s national health insurance authority. Under a pilot program, services to be covered include online follow-up consultations for common and chronic... Read More
Pharmaceutical companies seeking to deepen penetration of Singapore’s market are coming up against barriers to ensuring their intellectual property is protected and to keeping down costs of conducting clinical trials. The pharma industry is rising in importance in the country’s manufacturing sector.... Read More
Concerned India may lack sufficient supply of drugs to treat symptoms of the COVID-19 virus, the Indian government will restrict exports of certain pharmaceuticals produced within its borders, India’s Ministry of Commerce and Industry announced on March 3. Among the 26 active... Read More
More cancer patients are being diagnosed in China than in any other global market in the world. Cancer is rampant in China due to a number of factors including an aging population, smoking, air pollution, as well as other poor lifestyle choices.... Read More
As the use of artificial intelligence (AI) takes hold in Asia’s healthcare industry, researchers are collecting detailed health profiles of citizens and using the data to test treatments, monitor adverse drug reactions in patients, detect the risk of cognitive issues in children... Read More
As China pushes ahead with its policy of extracting price cuts from pharmaceutical manufacturers in exchange for access to its vast market, it is increasingly putting pressure on the profit margins of foreign and domestic drug manufacturers. Some drug firms are finding... Read More
With the COVID-19 virus shaking global markets and economies, anti-viral drug developers around the world are increasing efforts to develop treatments for the disease. Western pharmaceutical firms and research organizations have launched accelerated research and testing programs for novel coronavirus vaccines. Among... Read More
With the incidence of non-communicable diseases rising in Malaysia and as household incomes grow, the Southeast Asian nation presents fertile ground for both the pharmaceutical and medical device industries. According to analyst GlobalData, the medical device market in the country, worth $1.28... Read More
As part of the first phase of a broader trade pact signed by Chinese and U.S. officials in January, China has agreed to enact a system to prevent infringement of drug patents, a move that may boost protections for branded drugs in... Read More